Recognition of viral RNA by the retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs), including RIG-I and MDA5, initiates innate antiviral responses. Although regulation of RLRmediated signal transduction has been extensively investigated, how the recognition of viral RNA by RLRs is regulated remains enigmatic. In this study, we identified heterogeneous nuclear ribonucleoprotein M (hnRNPM) as a negative regulator of RLR-mediated signaling. Overexpression of hnRNPM markedly inhibited RNA virus-triggered innate immune responses. Conversely, hnRNPM-deficiency increased viral RNA-triggered innate immune responses and inhibited replication of RNA viruses. Viral infection caused translocation of hnRNPM from the nucleus to the cytoplasm. hnRNPM interacted with RIG-I and MDA5, and impaired the binding of the RLRs to viral RNA, leading to inhibition of innate antiviral response. Our findings suggest that hnRNPM acts as an important decoy for excessive innate antiviral immune response.
Introduction
Innate immune response provides the first line of host defense against invading microbial pathogens [1] . Upon infection, the conserved microbial components called pathogen-associated molecular patterns (PAMPs) are sensed by cellular pattern recognition receptors (PRRs). This leads to induction of type I interferons (IFNs), pro-inflammatory cytokines, and other downstream effector genes. These downstream effector proteins mediate innate immune and inflammatory responses to inhibit microbial replication and clear infected cells [1, 2] . Viral nucleic acids are major PAMPs that are sensed by the host cells after viral infection. Extracellular viral RNA is recognized by transmembrane and endosomal Toll-like receptor 3 (TLR3), which is expressed mostly in immune cells [3] , whereas intracellular viral RNA is detected by the retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs), including RIG-I and MDA5 [4] . Genetic studies have demonstrated that RIG-I and MDA5 play crucial roles in innate immune response to different types of RNA viruses [1] [5] . RIG-I and MDA5 utilize similar signaling pathways to induce downstream antiviral genes. Upon binding to viral RNA, RIG-I or MDA5 undergoes conformational changes and is recruited to the mitochondrial membrane-located adaptor protein VISA (also called MAVS, IPS-1 and Cardif) [6] [7] [8] [9] . This triggers the formation of large prion-like VISA polymers, which in turn serve as platforms for recruitment of TRAF2/3/5/6 through its TRAF-binding motifs [10, 11] . The TRAF proteins further recruit TBK1 and the IKK complex to phosphorylate IRF3 and IκBα respectively, leading to activation of IRF3 and NF-κB and induction of downstream antiviral effectors.
Both RIG-I and MDA5 contain two tandem caspase-recruitment domains (CARDs) at their N terminus, which mediate downstream signaling; a central DExD/H helicase domain with an ATP-binding motif; and a C-terminal RNA-binding domain [5] . Although RIG-I and MDA5 share similar signaling features and structural homology, various studies have demonstrated that the two helicases may discriminate among different ligands to trigger innate immune response. It has been demonstrated that RIG-I preferably recognizes viral 5'-ppp double-strand (ds) RNA and relatively short (approximately 300 bp) dsRNA, while MDA5 has higher affinity to long dsRNA [12] [13] [14] . Various studies have shown that RIG-I is essential for induction of downstream antiviral effector genes in response to RNA viruses including Sendai virus (SeV), vesicular stomatitis virus (VSV), Newcastle disease virus (NDV), influenza virus and Japanese encephalitis virus (JEV), whereas MDA5 is critical for the detection of picornaviruses, such as encephalomyocarditis virus (EMCV) [15, 16] .
RLR-mediated innate antiviral responses are regulated by distinct mechanisms. For examples, TRIM25, TRIM4, Riplet (also known as RNF135), TRIM13, USP4, USP3, USP15, USP21, CKII, PP1α/γ, and TRIM38 have been reported to regulate the post-translational modifications of RLRs [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] . MEX3C in stress granules enhances the affinity between viral RNA and RIG-I [28] . RAVER1 regulates MDA5-but not RIG-I-mediated antiviral immune response by promoting the binding of MDA5 to viral RNA [29] . More recently, it has been shown that ZCCHC3 acts as a co-receptor for the binding of RIG-I and MDA5 to viral RNA [30] . However, how RLR activation is monitored to prevent excessive innate antiviral response is unclear.
The heterogeneous nuclear ribonucleoprotein M (hnRNPM) contains three RNA recognition motif (RRM) domains. It has been shown that hnRNPM is involved in pre-mRNA splicing and diverse aspects of RNA metabolism, including translational control, telomere biogenesis, mRNA stability, and trafficking [31, 32] . Here we identified hnRNPM as a decoy of innate antiviral response. Viral infection led to export of hnRNPM from the nucleus to the cytoplasm, at where it impaired the binding of RLRs to viral RNA and subsequent innate antiviral response. Our findings reveal a mechanism on how the sensing of viral RNA by RLRs is properly regulated.
Results

hnRNPM inhibits RNA virus-triggered signaling
To identify candidate molecules involved in viral RNA-triggered innate immune response, we screened~10,000 independent human cDNA clones for their abilities to regulate IFN-β promoter activity by reporter assays and identified hnRNPM as a candidate protein. As shown in Fig 1A, overexpression of hnRNPM inhibited SeV-triggered activation of the IFN-β promoter, ISRE and NF-κB. Conversely, knockdown of hnRNPM facilitated SeV-and EMCV-induced transcription of the IFNB1, ISG56 and CXCL10 genes (Fig 1B) , but not IFN-β-induced transcription of the ISG15 gene ( Fig 1C) . Consistently, knockdown of hnRNPM enhanced SeVinduced phosphorylation of IRF3, TBK1, STAT1 and IκBα (Fig 1D) . These results suggest that hnRNPM negatively regulates RNA virus-triggered induction of antiviral genes.
hnRNPM-deficiency facilitates innate immunity to RNA virus
To investigate whether endogenous hnRNPM is required for innate immune response to RNA virus, we generated hnRNPM-deficient HEK293 individual clones by the CRISPR-Cas9 method. We found that transcription of the IFNB1, ISG56, and CXCL10 genes induced by SeV or VSV were markedly increased in hnRNPM-deficient cells (Fig 2A) . Consistently, transcription of the IFNB1, ISG56, and CXCL10 genes induced by cytoplasmic transfected high-or lowmolecular-weight (HMW or LMW) poly(I:C) was markedly increased in hnRNPM-deficient cells (Fig 2B) . Consistently, phosphorylation of TBK1, IRF3, IκBα, p65 and STAT1 induced by SeV was markedly increased in hnRNPM-deficient cells in comparison to control cells ( Fig  2C) .
To determine whether the effects of hnRNPM-deficiency are cell type-specific, we generated hnRNPM-deficient THP1 cells. We found that transcription of the IFNB1, ISG56, and CXCL10 genes induced by SeV (Fig 2D) and transfected LMW-poly(I:C) (Fig 2E) was markedly increased in hnRNPM-deficient THP1 cells in comparison to control cells. In similar experiments, hnRNPM-deficiency had no marked effects on transcription of these downstream genes induced by transfected DNA mimics such as HSV120 (a synthetic 120-mer dsDNA representing the genomes of HSV-1), HT-DNA (herring testis DNA) and VACV70 (70-mer dsDNA representing the genomes of VACV) (Fig 2F and S1B Fig) . Interestingly, we found that knockout of hnRNPM increased transcription of downstream genes induced by DNA virus HSV-1 (S1A Fig) , which indicate that hnRNPM regulates HSV-1-triggered innate immune responses in a viral DNA-independent manner. These results suggest that hnRNPM negatively regulates viral RNA-but not DNA-triggered induction of downstream effector genes.
hnRNPM-deficiency inhibits replication of RNA virus
Since hnRNPM inhibits RLR-mediated signaling, we examined the roles of hnRNPM in cellular antiviral response. Previous studies have demonstrated that RIG-I is essential for the antiviral innate response to NDV and VSV, whereas MDA5 is critical for the detection of EMCV. We found that the replication of GFP-tagged NDV and VSV was markedly inhibited in hnRNPM-deficient cells compared with control cells as monitored by GFP expression (Fig 3A  & 3B) . Plaque assays showed that viral titers of VSV and EMCV were much lower in hnRNPM-deficient cells compared with in control cells (Fig 3C) . These results suggest that hnRNPM-deficiency inhibits replication of RNA virus.
Infection of RNA virus induces export of hnRNPM from the nucleus to cytoplasm
Previous studies have shown that hnRNPM is mainly located in the nucleoplasm and plasma membrane, and barely detected in the cytoplasm [33] [34] [35] . We further examined the cellular transcriptions of downstream genes in THP-1 cells. hnRNPM-KO and control THP-1 cells were transfected with HSV120 for the indicated times before qPCR analysis.
https://doi.org/10.1371/journal.ppat.1007983.g002 localizations of hnRNPM before and after viral infection. Confocal microscopy revealed that hnRNPM was mostly localized in the nucleoplasm in uninfected cells. However, SeV or EMCV infection resulted export of hnRNPM from the nucleus to cytoplasm (Fig 4A) . Similarly, transfection of poly(I:C) also induced export of hnRNPM from the nucleoplasm to cytoplasm ( Fig 4B) . Consistent with confocal microscopy, subcellular fractionation analysis showed that hnRNPM was enriched in the cytosol after SeV infection. Notably, recombinant IFN-β also induced hnRNPM translocation (Fig 4C) . In addition, the hnRNPM translocation after viral infection was inhibited in RIG-I knockdown cells (Fig 4D) . Antiviral stress granules are reported to be a platform for the detection of viruses [36, 37] . Although it seems hnRNPM formed puncta structures in cytoplasm after virus infection, confocal microscopy experiments showed that hnRNPM was not co-localized with G3BP1 (as a marker of stress granules) ( Fig  4E) . These results suggest that RLR signaling activation causes export of hnRNPM from the nucleus to cytoplasm.
hnRNPM interacts with RIG-I and MDA5
We next investigated the molecular mechanisms that are responsible for the roles of hnRNPM in innate immune response to RNA virus. Results of reporter assays showed that overexpression of hnRNPM had no marked effects on RIG-I-and MDA5-mediated activation of the IFN-β promoter (Fig 5A) . Furthermore, knockdown of RIG-I inhibited the induction of IFNB mRNA by SeV in hnRNPM-deficient cells (Fig 5B) . In transient transfection and co-immunoprecipitation experiments, hnRNPM interacted with RIG-I and MDA5, but not with MITA, VISA, TBK1 and IRF3 ( Fig 5C) . Overexpression of hnRNPM had no effects on interaction between RIG or MDA5 with VISA ( S2A Fig) . Endogenous co-immunoprecipitation experiments indicated that hnRNPM interacted with RIG-I/MDA5 in a viral-infection-dependent manner ( Fig 5D) . We have further produced recombinant hnRNPM, RIG-I and MDA5 (280-1,025). Vitro protein pull-down analysis showed that hnRNPM can directly interact with RIG-I or MDA5 in RNA-free condition (Fig 5E) . These results suggest that hnRNPM acts at the level of RLRs. Both RIG-I and MDA5 contain two N-terminal CARD domains, a middle helicase domain, and a CTD, whereas hnRNPM contains three RNA recognition motif (RRM) domains ( Fig  5F) . Domain mapping experiments indicated that the CARD and the helicase-CTD of MDA5 could independently interact with hnRNPM, while the helicase-CTD but not CARD of RIG-I was responsible for its interaction with hnRNPM ( Fig 5F and S2B Fig) . Furthermore, we found that deletion of an individual RRM domain of hnRNPM had no marked effects on its interaction with RIG-I or MDA5. However, all other examined deletion mutants of hnRNPM failed to interact with RIG-I or MDA5 (Fig 5F and S2C Fig) . Reporter assays showed that wildtype hnRNPM and its mutants that interacted with RIG-I or MDA5 but not the other mutants inhibited SeV-induced activation of the IFN-β promoter (Fig 5G) . These results suggest that the association of hnRNPM with RIG-I or MDA5 mediates its inhibition of RLR-mediated signaling.
hnRNPM binds synthetic and viral RNA
Since hnRNPM is a heterogeneous nuclear ribonucleoprotein that contains three RRMs [38] , we determined whether hnRNPM binds to viral RNA similarly as RIG-I and MDA5. Previously, it has been shown that the CTD of RIG-I binds to 5'ppp-ssRNA, 5'ppp-dsRNA, and short blunt-ended dsRNA, with significantly higher affinity for 5'ppp-dsRNA [39] , whereas the CTD of MDA5 has higher affinity to long dsRNA such as synthetic poly(I:C). Pull-down experiments indicated that ectopically-expressed hnRNPM could bind to 5'ppp-dsRNA and (Fig 6A) . We also examined whether hnRNPM binds to viral RNA in infected cells by ''footprint" experiments [30] , [40] . After SeV infection (which is recognized by both RIG-I and MDA5), we immunoprecipitated hnRNPM and the immunoprecipitates were treated with RNase I. The protein-protected viral RNA was detected by RT-PCR with primers targeting various regions of SeV RNA. The results showed that hnRNPM could bind to naturally infected viral RNA similar as RIG-I and MDA5 (Fig 6B, S3 & S4 Figs) . Interestingly, hnRNPM appeared preferly to bind to the 5'-terminus of SeV RNA (Fig 6B, S3 & S4 Figs) and had a higher affinity with viral RNA in the late phase of infection (S4 Fig). Confocal microscopy analysis confirmed the colocation between poly(I:C) and hnRNPM (Fig 6D) . These experiments suggest that hnRNPM can directly bind to synthetic and viral RNA. Furthermore, pulldown experiments revealed that the individual RRM-deleted mutants of hnRNPM as well as hnRNPM (aa281-653) and hnRNPM (aa204-729) could bind to 5'ppp-dsRNA or SeV RNA (Fig 6C) . These results indicate that RRM regions that bind cellular and viral RNA are different. Notably, although hnRNPM (aa281-653) and hnRNPM (aa204-729) could bind to viral RNA, they lost the ability to inhibit SeV-induced activation of the IFN-β promoter (Fig 5G) . These findings suggest that the binding of hnRNPM to viral RNA is insufficient for regulating RLR-mediated signaling.
hnRNPM inhibits detection of viral RNA by RIG-I and MDA5
Finally, we investigated whether hnRNPM regulates sensing of viral RNA by RIG-I and MDA5. The ''footprint" experiments showed that overexpression of hnRNPM inhibited the binding of RIG-I to SeV RNA (Fig 7A and S5A Fig) . Conversely, deficiency of hnRNPM enhanced the binding of RIG-I to SeV RNA (Fig 7B and S5B Fig) . Furthermore, pull-down experiments also indicated that the binding of RIG-I to 5'ppp-dsRNA or MDA5 to poly(I:C) was enhanced in hnRNPM-deficient cells in comparison to control cells (Fig 7C) . We further produced recombinant hnRNPM and MDA5(280-1,025) in bacteria and immunoprecipitated Flag-tagged RIG-I from transfected HEK 293 cells for microscale thermophoresis technology (MST) experiments in vitro. The results showed that hnRNPM bound to dsRNA (25 bp) with an affinity of Kd = 22.1 ± 0.439 nM, which was higher than that of MDA5 (Kd = 131 ± 4.41 nM) and RIG-I (Kd = 69 ± 3.29 nM) with dsRNA ( Fig 7D and S5C Fig) . Interestingly, recombinant hnRNPM caused approximately 10-and 3-fold decrease of the affinities of RIG-I and MDA5 to dsRNA respectively (Fig 7D and S5C Fig) . These results suggest that hnRNPM impairs the binding of RIG-I and MDA5 to viral RNA.
Discussion
Recognition of viral RNA by RLRs is essential for the initiation of innate antiviral response initiation. Although the regulation of RLR-mediated downstream signaling have been extensively investigated, little is known about the regulatory mechanisms of the recognition of viral RNA by RLRs. Recently, we identified ZCCHC3 as a co-receptor for RIG-I and MDA5 by facilitating the sensing of viral RNA [30] . In addition, MEX3C and RAVER1 have been reported to facilitate the recognition of viral RNA by RIG-I and MDA5 respectively [28, 29] . However, how these processes are negatively regulated remains enigmatic. In the current study, we identified hnRNPM as an inhibitor of RLR-mediated innate immune response by impairing the binding of RIG-I and MDA5 to viral RNA. Overexpression of hnRNPM inhibited SeV-triggered activation of ISRE, NF-κB, and the IFN-β promoter, while deficiency of hnRNPM had the opposite effects. In addition, the replication of RNA virus was decreased in hnRNPM-deficient cells compared with control cells. These data established a critical role for hnRNPM in innate immune response to viral RNA.
We found that hnRNPM underwent re-distribution between nucleus and cytoplasm during RNA virus infection. hnRNPM was mostly localized in the nucleus in rest cells. Following infection, hnRNPM was translocated from the nucleus to cytoplasm, which was impaired in RIG-I knockdown cells. Furthermore, hnRNPM was also translocated from the nucleus to cytoplasm in IFN-β-treated cells. These results suggest that hnRNPM translocation is dependent on RLRs.
Several evidences suggest that hnRNPM inhibits RNA virus-triggered innate immunity by antagonizing RNA sensing of RLRs. Firstly, viral infection caused export of hnRNPM from the nucleus to cytoplasm, indicating a cytoplasmic role of hnRNPM after viral infection. Second, hnRNPM was associated with RIG-I and MDA5 and their interactions were important for the functions of hnRNPM. Third, overexpression of hnRNPM inhibited the binding of RIG-I to SeV RNA. Conversely, deficiency of hnRNPM enhanced the binding of RIG-I to SeV RNA. Recombinant hnRNPM caused approximately 10-and 3-fold decrease of the affinities of RIG-I and MDA5 to dsRNA respectively. These results collectively suggest that hnRNPM is an inhibitor for RLR-mediated innate immune response by impairing viral RNA sensing by RIG-I and MDA5.
Our results revealed that the classical cellular mRNA binding regions (RRM) of hnRNPM differs from its viral RNA binding regions. The mutants containing partial RRM regions such as 1-149, 1-281 and 71-281 are lack of viral RNA binding activity while the mutant 281-653 being lack of all three RRM domains had a stronger affinity to viral RNA.
Although hnRNPM binds to dsRNA, the binding is insufficient for regulating RLR-mediated signaling. Several truncations of hnRNPM, aa281-653 and aa204-729, that could bind to RNA but failed to interact with RIG-I and MDA5, had no effects on SeV-triggered activation of the IFNB promoter. hnRNPM appeared to prefer to bind to the 5'-terminus of SeV RNA, but inhibited the binding of RIG-I to diverse regions of SeV RNA. The regions of RIG-I that interact with hnRNPM overlapped with its viral RNA binding regions. These results collectively suggest the functions of hnRNPM on RLR-mediated innate immune response are mostly dependent on its association with RLRs instead of RNA binding.
Interestingly, we also found that hnRNPM deficiency enhanced DNA virus -triggered expression of downstream genes. However, hnRNPM deficiency had no significant effects on the induction of downstream genes by transfected DNA mimics such as HSV120, HT-DNA and VACA70. These results suggest that hnRNPM regulates HSV-1-triggered innate immune responses in a viral DNA-independent manner. Previous studies have implicated that RIG-I also detected dsRNA produced by herpesviruses [41] [42] [43] [44] [45] . We propose a possibility that hnRNPM is partly involved in HSV-1-triggered innate immune signaling by regulating the sensing of HSV-1-derived RNA by RIG-I. In conclusion, our study suggests that hnRNPM is a decoy of innate antiviral response by impairing the sensing of viral RNA by RLRs, which provides a critical control mechanism of viral RNA sensing for the host to avoid excessive immune response. dual-specific luciferase assay kit (Promega); puromycin and EZ-link psoralen-PEG 3 -biotin and streptavidin agarose resin (Thermo); protein G sepharose (GE Healthcare); anti-Flag affinity gel (Biomake, B73102); RNAiso plus (Takara); and recombinant IFN-β (R&D systems) were purchased from the indicated companies.
Materials and methods
Reagents, antibodies, cells and viruses
Anti-Flag (F3165), anti-β-actin (A2228) and anti-β-tubulin (T8328) were from SigmaAldrich. Anti-phospho-IκBα (Ser32/36) (5A5), anti-phospho-IRF3 (Ser396) (4D4G), antiphospho-STAT1 (Tyr701) (58D6) and anti-phospho-p65 (Ser536) were from Cell Signaling Technology. Anti-LMNB1 (12987-1-AP) was from ProteinTech. Anti-G3BP1(210-323aa) (611126) was from BD Biosciences. Anti-HA (16B12) was from Covance. Anti-TBK1 (ab109735), anti-phospho-TBK1 (Ser172) (ab109272) were from Abcam. Anti-IRF3 (FL-425), anti-p65 (C-20) (sc-372), anti-STAT1 (C-111) were from Santa Cruz Biotechnology. Goat anti-mouse IgG (R37116) or donkey anti-rabbit (R37119) conjugated to Alexa Fluor 594 and goat anti-mouse IgG (A-10684) conjugated to Alexa Fluor 488 were purchased from Thermo Fisher. Mouse antisera against hnRNPM, IκBα, RIG-I and MDA5 were raised against purified recombinant human hnRNPM (1-729aa), IκBα, RIG-I (1-200aa) and MDA5 (1-200aa) . Rabbit antisera against SeV was raised against purified SeV.
Human embryonic kidney 293 (HEK293, CRL-1573), Human acute monocytic leukemia cell line (THP-1) and Henrietta Lacks (HeLa, CCL-2) cells were purchased from American Type Culture Collection, and Vero cells were purchased from China Center for Type Culture Collection (Wuhan, China). HEK293T cells were originally provided by G. Johnson (National Jewish Health, Denver, CO). The strains (BL21 and DH5α) were purchased from ATCC.
SeV, VSV (Indiana Strain), NDV and HSV-1 were previously described [46, 47] . EMCV was provided by Dr. H. Yang (China Agricultural University).
DNA oligonucleotides
The following oligonucleotides were used to stimulate cells: VACV70: 5'-CCATCAGAAAGAGGTTTAATATTTTTGTGAGACCATGGA AGAGAGAAAGAGATAAAACTTTTTTACGACT-3'; HSV120: 5'-AGACGGTATATTTTTGCGTTATCACTGTCCCGGATTGGAC ACGGTCTTGTGGGATAGGCATGCCCAGAAGGCATATTGGGTTAACCCCT TTTTATTTGTGGCGGGTTTTTTGGAGGACTT-3'. 
Constructs
RIG-I or MDA5 and their mutants, Flag or HA-tagged hnRNPM and their truncation mutants, pGEX6p-1-GST-hnRNPM and pGEX6p-1-GST-MDA5 (280-1025) were constructed by standard molecular biology techniques. The other expression and reporter plasmids were previously described [9] .
Transfection and reporter assays
HEK293 cells were transfected by standard calcium phosphate precipitation method. To normalize for transfection efficiency, 0.01 μg of pRL-TK (Renilla luciferase) reporter plasmid was added to each transfection. Luciferase assays were performed using a dual-specific luciferase assay kit. Firefly luciferase activities were normalized on the basis of Renilla luciferase activities.
RNA interference
Double-stranded oligonucleotides corresponding to the target sequences were cloned into the pSuper. Retro-RNAi plasmid (Oligoengine).
The following sequences were targeted for hnRNPM mRNA. 
Subcellular fractionation
Nuclear and cytoplasmic fractions extraction of HEK293 cells were generated according to the instruction of Nuclear and Cytoplasmic Protein Extraction Kit (PPLYGEN, P1201).
In vitro RNA pull-down assays Poly(I:C) and 5'ppp-dsRNA was conjugated to biotin by UV (365 nm wave-length) cross-linking for 1 hour. HEK293 cells transfected with the indicated plasmids were lysed in Pre-lysis buffer pre-treated with DEPC. Lysates were incubated with biotinylated-5'ppp-dsRNA or biotinylated-poly(I:C) for 2 hours at room temperature, and then incubated with streptavidin beads for another 1 hour at room temperature. The beads were washed four times with lysis buffer and analyzed by immunoblots with the indicated antibodies.
Recombinant protein purification
The pGEX-6p-1-GST plasmids encoding hnRNPM and MDA5(280-1025) were transformed into BL21 competent cells. Expression of the proteins was induced with 0.1 mM IPTG at 16˚C for 24 hours. The proteins were purified with GST resins and eluted with elution buffer (PBS, 100 mM Tris-HCl pH 8.8, 40mM reduced glutathione). To obtain purified RIG-I, Flag-RIG-I plasmid was transfected into HEK293 cells by standard calcium phosphate precipitation method. The expressed Flag-RIG-I protein was immunoprecipitated with anti-Flag affinity gel and eluted with 3×Flag peptides.
In vitro protein pull-down assays
Purified recombinant protein hnRNPM and MDA5/RIG-I were incubated in PBS with RNase I at 4˚C for 3 hours. Lysates were respectively immunoprecipitated with anti-MDA5 and protein G beads (50 ul) or anti-Flag affinity gel at 4˚C for another 2 hours. GST was used as negative control. Bound proteins were analyzed by immunoblots with the indicated antibodies.
Microscale thermophoresis technology (MST)
MST analysis was performed using a NanoTemper Monolith NT.115 instrument (NanoTemper Technologies GmbH). For detecting affinity between dsRNA and GST-hnRNPM, Flag-RIG-I or GST-MDA5, 20 nM Cy5-labeled 25 bp dsRNA (Sangon Biotech, China) was mixed with different concentrations of proteins in PBS with 100 mM Tris-HCl (pH 8.8). GST was used as negative control. Samples were loaded into Premium Coated Capillaries and MST measurements were performed using 20% MST power and 40% LED power at 25˚C. Laser-on and -off times were 30 and 5 s respectively. NanoTemper Analysis 1.2.20 software was used to fit the data and to determine the apparent Kd values.
RNA-binding protein immunoprecipitation (RIP)
HEK293 cells were transfected with the indicated HA-or Flag-tagged plasmids for 20 hours, then infected with SeV for 1 hour, washed with medium and cultured for 2 more hours. Cell lysates were immunoprecipitated with IgG or anti-HA (2 μg) and protein G beads (50 μl) at 4˚C for 3 hours. The immunoprecipitates were treated with diluted RNase I (1:25 in PBS) at 37˚C for 5 min. The bead-bound immunoprecipitates were washed for 3 times with lysis buffer containing RNase inhibitors. The protein and RNA complexes were eluted with 200 μL TE buffer containing 10 mM DTT at 37˚C for 30 min. The RNA was extracted using Trizol reagent before qPCR analysis for SeV RNA. The SeV genome primer sequences were described in S1 Table.
Confocal microscopy
Confocal microscopy was performed as previously described [48] . Briefly, cells infected with virus or transfected poly(I:C) for the indicated times were fixed with 4% paraformaldehyde for 10 min at 25˚C and then permeabilized and stained with indicated antibodies by standard protocols. The stained cells were observed with a ZEISS confocal microscope under a 100× oil objective.
Viral plaque assay
Host cells ( 5×10 5 ) cultured in 12-well plates were infected with viruses at the respective MOI for 1 hour, then washed with PBS and cultured with 1 ml fresh complete medium. The plates were incubated for 36 hours post-infection at 37˚C, 10% CO 2 . The media were collected and used for plaque assays on monolayers of Vero cells seeded in 24-well plates. The Vero cells were infected by incubation for 1 hour at 37˚C with serial dilutions of collected media. After infection for 1 hour, the cells were overlaid with 1.5% methylcellulose and then incubated for about 48 hours. The overlay was removed, and cells were fixed with 4% paraformaldehyde for 15 min and stained with 1% crystal violet for 30 min before plaque counting.
Statistical analysis
Unpaired Student's t test was used for statistical analysis with GraphPad Prism Software. p < 0.05 was considered significant. 
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